ATVR
This asset is not currently listed on any markets available through Pearler. The information on this page may be inaccurate or out of date.
Activeport Group Ltd
π¦πΊ ASX
π Overview
π Performance
π΅ Cost
π€ Advanced
π¨βπ©βπ§βπ¦ Community
π
N/A
Growth
4 months growth
π΅
$ 500
Minimum Order
Due to regulatory requirements
π
1
Pearlers Invested
Since January 2020
π Overview
Key information
π Fund Overview
Activeport Group Ltd - Rights - Applications Close 01-Nov-2024
π Performance
Price History
0.00%
1M
All Time
Graph
Table
Unsure how much or often to invest?
ποΈ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out βπ΅ Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out ββ±οΈ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out βπ΅ Costs
πΌ
N/A
Management Fee
Included in unit price, not charged by Pearler
πΈ
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
πΈ Net fee calculatorπ€ Advanced information
Technical Info
π° Price*
$0.00
*Price may be up to 24 hours old
π©βπ©βπ¦ Community Insights
How our community is investing
π Pearlers invested in ATVR
0
π Total Capital Earnings
N/A
π Average investment frequency
N/A
π΅ Average investment amount
N/A
β° Last time a customer invested in ATVR
N/A
ATVR investor breakdown
π΅ Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
Less than 50k
πΆ Age of investors
18 - 25
26 - 34
35 - 90
π Legal gender of investors
Female
Male
Pearlers who invest in ATVR also invest in...
IVV.AX was created on 2007-10-10 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.
π Performance (5Yr p.a)
18.33%
π Share price
$63.14 AUD
πΊπΈ UNITED STATES
π HIGH PRICE GROWTH
Argo Investments Ltd is a AU-based company operating in industry. The company is headquartered in Adelaide, South Australia. Argo Investments Limited is an Australia-based listed investment company (LIC). The firm manages a diversified portfolio of Australian shares with an internally managed business model. The principal activities of the Company include the investment of funds in Australian listed securities and short-term interest-bearing securities. Its investment objective is to maximize long-term shareholder returns through reliable fully franked dividend income and capital growth. Its investment portfolio comprises approximately 90 Australian companies from across a range of industries. Its portfolio includes investments in various sectors, such as materials, other financials, banks, healthcare, consumer staples, industrials, energy, consumer discretionary, property, utilities, listed investment companies, and others. Its subsidiary, Argo Service Company Pty Ltd, is engaged in providing investment management and administration operations for the Company.
π Performance (5Yr p.a)
1.08%
π Share price
$9.01 AUD
Classic Minerals Ltd. engages in exploration of mineral resource-based projects, focusing on gold and nickel. The company is headquartered in Perth, Western Australia. The company went IPO on 2013-05-24. The firm holds approximately 578 square kilometers of tenements across two regional exploration areas in minerals-rich West Australia. The company is focused on gold deposits in Western Australia's Goldfields region at Forrestania and Kat Gap. Its flagship Kat Gap Gold Project is located approximately 170 kilometers (km) south of Southern Cross and also 50 km south of the Company's Forrestania Gold Project. The Forrestania Gold Project is located approximately 120 km south of Southern Cross, Western Australia and contains the Lady Ada and Lady Magdalene deposits. Its Fraser Range Project (E28/1904) is approximately 40 km to the northeast of Sirius Nova deposit on the Fraser-Albany Mobile Belt, approximately 160 km east southeast of Kambalda and is of interpreted Proterozoic age. The company holds approximately 28 km of strike across 84 square kilometers.
π Performance (5Yr p.a)
-9.62%
π Share price
$0.00 AUD
βοΈ MINING
Genesis Minerals Ltd. engages in the exploration and development of gold deposits in Western Australia. The company is headquartered in Perth, Western Australia. The company went IPO on 2007-08-02. The principal activities of the Company are processing at Mt Morgans, exploration of its 100% owned tenement packages at Laverton and Leonora and pre-development activities at the Ulysses Gold Project. Mt Morgans comprises a portfolio of open pit and underground mineral resources, a 2.9 million tons per annum (Mtpa) conventional carbon-in-leach processing plant. The Leonora Gold Project is located 30 kilometers (km) south of Leonora and 200km north of Kalgoorlie, in the Eastern Goldfields of Western Australia. The Barimaia Gold Project is in the Murchison District of Western Australia, 10 Km southeast of the Mt Magnet Gold Mine. Its Leonora operations also include Gwalia underground mine, 1.4Mtpa Leonora mill, Tower Hill project, the Zoroastrian project, and the Aphrodite and Harbour Lights refractory projects. The firm also holds Bruno-Lewis and Raeside gold tenements in Western Australia.
π Performance (5Yr p.a)
157.78%
π Share price
$3.20 AUD
βοΈ MINING
VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.
π Performance (5Yr p.a)
13.05%
π Share price
$141.26 AUD
π GLOBAL
β³οΈ DIVERSIFIED
π HIGH PRICE GROWTH
π€ TECHNOLOGY
Want more shares? Try these...
Amplia Therapeutics Ltd. is a medical biotechnology company, which engages in the development of drugs for potential use in multiple indications including oncology and chronic fibrosis. The company is headquartered in Melbourne, Victoria. The company went IPO on 2013-12-23. The firm is focused on developing proprietary, orally available, small molecule Focal Adhesion Kinase (FAK) inhibitors as candidate drugs for the treatment of cancer and various fibrotic diseases. The firm's pipeline includes narmafotinib (AMP945) and AMP886. narmafotinib is a selective and potent inhibitor of FAK and is in clinical development for pancreatic cancer and advanced preclinical development for idiopathic pulmonary fibrosis (IPF). The firm's second pipeline drug, AMP886, inhibits FAK and inhibits two key disease drug targets (VEGFR3 and FLT3). This drug is being evaluated in preclinical models of cancer. Its fibrosis program uses its FAK inhibitors to block fibrosis and cell migration in cancers. Its cancer Program is directed at using its FAK inhibitors to block FAK activity in the cancer cells and the surrounding tissue and therefore block survival/proliferation signals.
π Performance (5Yr p.a)
0.71%
π Share price
$0.08 AUD
𧬠BIOTECHNOLOGY